Merck · company speakers →
focused on findings involving M0324, an antibody-based construct designed to activate the CD40 immune signaling pathway, but only in the presence of high MUC1 levels in the vicinity.
Is this you? Claim this profile →
No public contact links on file.
Sourcing speakers for your event?
Browse the speaker directory →